Back
INmune Bio Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
41
INMB
INmune Bio
Last Price:
$8.13
Seasonality Move:
36.2%
Sell
48
SRPT
Sarepta Therapeutics
Last Price:
$74.08
Seasonality Move:
14.66%
Sell
41
INmune Bio (INMB)
is a Sell
Is INmune Bio a Buy, Sell or Hold?
-
The current INmune Bio [INMB] share price is $8.12. The Score for INMB is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
-
INMB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $74.10. The Score for SRPT is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
INMB Stock Price Chart
What is INmune Bio's stock price today?
-
The INmune Bio share price today is $8.12The current trend is relatively stagnant and INMB is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $74.10Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight selling pressure.
INMB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 50.29 | Buy |
| Chaikin Money Flow: | 123366 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.71 - 8.91) | Sell |
| Bollinger Bands (100): | (4.92 - 8.36) | Buy |
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -8.7 | Sell |
| Relative Strength Index (14 RSI): | 27.9 | Sell |
| Chaikin Money Flow: | -367389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (88.59 - 111.17) | Sell |
| Bollinger Bands (100): | (103.29 - 127.87) | Sell |
INMB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.02 | Buy |
| 20-day SMA: | 8.07 | Buy |
| 50-day SMA: | 8.05 | Buy |
| 200-day SMA: | 6.88 | Buy |
| 8-day EMA: | 8.03 | Buy |
| 20-day EMA: | 8.13 | Sell |
| 50-day EMA: | 7.79 | Buy |
| 200-day EMA: | 7.38 | Buy |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 87.22 | Sell |
| 20-day SMA: | 97.87 | Sell |
| 50-day SMA: | 108.64 | Sell |
| 200-day SMA: | 125.16 | Sell |
| 8-day EMA: | 84.58 | Sell |
| 20-day EMA: | 94.74 | Sell |
| 50-day EMA: | 105.16 | Sell |
| 200-day EMA: | 118.38 | Sell |
INmune Bio Earnings Growth & INMB Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.29 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
INmune Bio Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Sarepta Therapeutics Technical Analysis
| Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||